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Introduction
Obesity is a major risk factor for much physical and psychological comorbidity, and in recent years it has become a worldwide epidemic, with dramatic consequences for public health. Through a meta-analysis, Beydoun et al. (2008) suggests that, even when sociodemographic, lifestyle and health-related comorbid factors are controlled for, obesity still plays an independent role in the aetiology of dementia (Beydoun et al. 2008) . Indeed, numerous studies have consistently reported that obesity is linked to cognitive deficits (Gunstad et al. 2007; Smith et al. 2011; Spyridaki et al. 2014) , with the potential mechanisms being attributed to elevated energy metabolic indices (e.g. leptin, insulin and glucose; Razay & Wilcock, 1994; Vanhanen et al. 1998; Harvey, 2007; Gunstad et al. 2008; Messier et al. 2011) , low-grade systemic inflammation (Smith et al. 2011) , poorer prefrontal cerebral metabolism (Volkow et al. 2009 ) and neuronal degradation (Smith et al. 2011) .
Many different cognitive domains are compromised in the presence of increased adiposity (Gunstad et al. 2007; Knecht et al. 2008; Spyridaki et al. 2014) . A previous study reported that individuals with obesity have lower neural activity in the parietal cortex compared with normal-weight individuals in resting conditions (Karhunen et al. 1997) . More recently, Balodis et al. (2013) found that obese subjects relative to obese individuals with binge eating disorder showed different neural activity during the incongruent and congruent conditions in brain areas involved in self-regulation and impulse control when performing the Stroop colour-word interference task, suggesting that the inferior parietal lobule, midbrain and thalamus are affected in the obese individuals without binge eating disorder.
The covert orienting of a visuospatial attention task (COVAT) provides a valid and reliable measure of an individual's capacity to direct visuospatial attention to different areas of the visual field (Posner, 1980) . When the target appears in an unprecued location, three different attentional control modes (disengaging, shifting and engaging of attention) are elicited, which are associated with the function of specific brain areas, including the posterior parietal lobe, midbrain and thalamus, respectively (Posner & Raichle, 1994) . Some researchers have also claimed that the parietal regions are related to covert orienting and redirecting of covert orienting (Corbetta & Shulman, 2002; Rushworth et al. 2003) . Accordingly, when an individual performs COVAT, any manifest deficit seems to provide some information about brain lesions (Posner & Raichle, 1994) . Additionally, as the visuospatial attention task allows for the manipulation of executive function demands not only on attention and visuospatial processing abilities, but also on inhibitory control of attention based on the response requirements (Posner & DiGirolamo, 1998; Theeuwes, 2010) , such a cognitive task was thus used to elucidate the association between obesity and neurocognitive performance in the present study.
The cognitive tasks (e.g., visuospatial attention protocol) coupled with concomitant electrophysiological recording [e.g. event-related potential (ERP)] can elicit various visual response ERP components (Tsai et al. , 2017 . Among these, the endogenous P3 reflects attention-related brain activity (i.e. the resource allocation necessary for attention; Neuhaus et al. 2009; Perchet & García-Larrea, 2000; Polich, 2007) and is also involved in conflict-related brain activity (i.e. the attentional resources that are allocated to inhibit a response efficiently; Jonkman et al. 2003) . A recent study reported that children with obesity showed smaller P3 amplitudes than normal-weight ones when performing the visuospatial attention task (Tsai et al. 2016a) . Therefore, the ERP component was used in the present study to gain a better understanding of the correlation between obesity-related biochemical markers and neurocognitive performance of visuospatial attention in individuals with obesity.
Leptin, a circulating cytokine secreted by adipocytes, can cross the blood-brain barrier and bloodcerebrospinal fluid barrier via its central receptors in the hypothalamus and choroid plexus to elicit a negative feedback adiposity signal to regulate the body's energy homeostasis (Rosenbaum & Leibel, 2014) . Previous studies reported the neurotrophic and antiapoptotic role of leptin; however, insensitivity to this hormone (i.e. inability to respond to leptin because of dysfunctional leptin receptors) in the CNS plays a role in the neurocognitive impairments (e.g. prolonged P3 latency) seen in individuals with obesity or obesity-linked disorders, such as type 2 diabetes (Harvey, 2007; Braverman et al. 2014) . Given that individuals with excessive body fat or higher body mass index (BMI) show higher concentrations of leptin because of greater leptin resistance (Considine, 2005; Haleem, 2014) , the impaired neurocognitive performances in adults with obesity could thus be associated with higher leptin concentrations (Harvey, 2007; Gunstad et al. 2008) .
Likewise, insulin has been shown to have beneficial effects on the brain in animal studies, such as promoting neuronal outgrowth (Wallace et al. 1997) and reducing spatial learning deficits after transient forebrain ischaemia (Voll et al. 1989) . Additionally, insulin modulates noradrenaline uptake in the hippocampus (Boyd et al. 1985) , which is highly associated with the regulation of selective attention (McEwen, 1988) . Previous studies also suggested that insulin could improve the working memory and attention in healthy humans (Kern et al. 2001) . However, insulin resistance (IR) results in chronic hyperinsulinaemia/chronically high insulin concentrations, which may impair cognitive functioning (Razay & Wilcock, 1994; Vanhanen et al. 1998) . Most importantly, the association of glucoregulation and cognition is highly related to the function of insulin in the brain (Messier et al. 2011) . Glycaemic status is sensitive to neurophysiological parameters, as evidenced by increased P3 latency and decreased serum glucose concentrations (Thomas et al. 1997) and by a significant decrease in P3 latency and enlargement in P3 amplitude after reduction of blood glucose concentrations via exercise in adults with type 2 diabetes (Kyizom et al. 2010) . These findings suggest that increasingly abnormal glucoregulation is associated with increasing neurocognitive impairments.
Lipid accumulation induces adipocytes to produce a variety of cytokines (e.g. leptin and adiponectin), which contribute to activation of inflammatory pathways and, in turn, increase expression low-grade inflammatory mediators [e.g. interleukin (IL)-6, IL-1β, and tumour necrosis factor-α (TNFα); Toffanin et al. 2010] . The association between cognition and peripheral inflammatory marker concentrations, including IL-6, IL-1β, TNFα and C-reactive protein (CRP), has been reported in cross-sectional studies of the general population (Oztürk et al. 2007; Alley et al. 2008) , with higher concentrations of inflammatory cytokines being associated with lower levels of cognitive function (e.g. spatial abilities; Wesselingh et al. 1997; Brabers & Nottet, 2006; Alley et al. 2008; Cvejic et al. 2014; Walsh et al. 2014) , because the classic pro-inflammatory cytokines (e.g. IL-6, IL-1β and TNFα) are primarily negative modulators of the proliferation of neural stem cells in the hippocampus, which is involved with memory and spatial abilities (Ryan & Nolan, 2016) . Recently, Hu et al. (2016) found that raised inflammatory cytokines (e.g. CRP) were associated with poorer ERP performance (i.e. P3 latency). Moreover, Matas et al. (2010) indicated that adults with multiple sclerosis who have been found to have higher serum concentrations of neuroinflammatory factors (e.g. IL-6, IL-1β and TNFα; Maimone et al. 1991) showed abnormalities in cognitive potential (e.g. ERP P3) when performing a cognitive task involving cognitive processing, attention and auditory discrimination (Matas et al. 2010) .
Previous research has rarely tried to investigate the neurophysiological mechanisms related to executive cognitive function in obese adults. In addition, although some obesity-related metabolic and inflammatory markers have been shown to be linked with neuropsychological performances involving attention and spatial abilities (McEwen, 1988; Voll et al. 1989; Wesselingh et al. 1997; Kern et al. 2001; Brabers & Nottet, 2006; Alley et al. 2008; Braverman et al. 2014; Cvejic et al. 2014; Walsh et al. 2014 ) and neurophysiological indices (e.g. ERP P3 component; Thomas et al. 1997; Kyizom et al. 2010; Matas et al. 2010; Hu et al. 2016) , the potential relationships between these biochemical markers and poorer neurocognitive performance in individuals with obesity have not been explored to date. The aims of the present study were thus twofold: (i) to explore neurophysiological performance using the ERP P3 activity in adults with obesity when performing the visuospatial attention task, because the ERP component is responsive to deterioration of attention, thereby acting as a useful indicator for evaluation of cognitive performance; and (ii) to ascertain whether the relationships between neurocognitive performance and the biochemical markers occur independently of factors known to be associated with both obesity and neurocognitive dysfunction (i.e. cardiorespiratory fitness). We hypothesized that young adults with obesity would show poorer neurocognitive performances when performing the visuospatial attention task and higher concentrations of energy metabolic and inflammatory markers. In addition, we also hypothesized that there would be an inverse relationship between these markers and decreases in neurocognitive performances in individuals with obesity.
Methods

Ethical approval
The participants gave informed consent to participate in the experiment, which was approved by the Institutional Review Board of National Cheng Kung University Hospital (approval number: NCKUH IRB: 8800-4-03-005). This study conforms to the standards set by clause 35 of the Declaration of Helsinki, except for registration in a database. Participants provided written informed consent before beginning the study.
Participants
With regard to Asian populations, the Western Pacific Regional Office of the World Health Organization (WPRO), led by the International Association for the Study of Obesity and the International Obesity Task Force, proposed a BMI of 23.0-24.9 kg m −2 for overweight and BMI ࣙ25.0 kg m −2 for obesity based on the related morbidity data and mortality risks (World Health Organization, 2000; Wen et al. 2009 ). The obese participants in the present study were thus defined as individuals with BMI ࣙ25.0 kg m −2 . According to this criterion, and after conducting an a priori power analysis which indicated that ß27 participants was the minimum required sample size for each group to obtain a power level of 0.95, 30 obese adults and 30 sex-matched healthy-weight (BMI <23.0 kg m −2 ) adults aged between 19 and 26 years old were recruited from the same university. All participants were non-smokers and right handed, as measured by a handedness inventory (Chapman & Chapman, 1987) . They reported being free of any metabolic or cardiovascular diseases, neurological or psychiatric disorders, a history of head injury, or medication intake that influenced CNS functioning. None of the participants showed any symptoms of depression, as measured by the Beck depression inventory II (BDI-II; all scored below 13; Beck et al. 1996) , or cognitive impairment, as measured by the mini-mental state examination (MMSE; all scored below 24; Folstein et al. 1975) . All participants had normal or corrected-tonormal vision. Demographic and body composition [e.g. BMI and percentage fat as measured with dual-energy X-ray absorptiometry (DXA)] data for this sample are provided in Table 1 .
Experimental procedure
All participants were required to make two visits to the cognitive neurophysiology laboratory. During the first visit, the research assistant explained the experimental procedure. She then asked the participants to complete an informed consent form, as well as a medical history and demographic questionnaire, MMSE, BDI-II and a handedness inventory. Memory depth was estimated by the digit span component of the Wechsler-IV adult intelligence test (Wechsler, 2008) . The participants' height and weight were also measured to calculate their BMI. After completing all questionnaires, they were then fitted with a Polar heart rate (HR) monitor (RX800CX; Polar, Helsinki, Finland) and took the 3 min step test to assess their cardiorespiratory fitness.
During the second visit, in the same week, the participants arrived after fasting for 12 h and refraining from strenuous exercise and alcohol intake for 24 h. Each participant was asked to arrive at the laboratory at about 08.00-08.30 h and sat in an adjustable chair in front of a computer screen (with a width of 43 cm) in an acoustically shielded room with dimmed lights. An electrocap and electro-oculographic (EOG) electrodes were attached each participant's scalp and face before the cognitive task test. The viewing distance was ß75 cm. After 10 practice trials to help the participants became familiar with the visuospatial attention protocol, they underwent fasting blood sampling between 09.00 and 09.30 h. The participants then underwent a simultaneous formal cognitive task test with concomitant electrophysiological recording, during which they were asked to respond as quickly and accurately as possible. Upon completion of the cognitive task, a DXA measurement was made to assess body composition. All the participants performed the experiment at the same time of day to control for circadian influences. Endocrine and neurocognitive performance in obesity
Cognitive task: visuospatial attention protocol
A visuospatial attention task programmed using E-prime software was used in the present study (Tsai et al. 2016a) . All the stimuli were presented on a black background. The white fixation cross, subtending a visual angle of 0.5 deg × 0.5 deg, served as the central fixation point, and was horizontally positioned midway between two empty white square boxes (each 2 cm × 2 cm) arranged 1 cm from the fixation cross that served as potential locations for target delivery. A trial began with a 3 s countdown, followed 1000 ms later by the appearance of the two white stimulus square boxes and the white fixation cross which, in turn, was followed 1000 ms later by the replacement of the fixation cross by a yellow single arrow cue (1.5 cm in length), which pointed to the right or left to indicate the possible position of the upcoming target. After a further 350 ms interval between cue onset and the appearance of the target [i.e. stimulus onset asynchrony (SOA)], a green circle target stimulus (with a diameter of 1.6 cm) appeared in the centre of either the left or the right white stimulus box. All of the stimulus display, which fell into the foveal region (2 deg) of the visual field, remained until the end of the trial. The participants were asked to press the left 'N' or right 'M' button of the computer keyboard with the index or middle finger of the dominant hand as quickly as possible upon detection of the green circle target. The screen cleared and then then next trial began 1500 ms later. If there was a lack of response, a new trial was started after a period of 3 s. Accordingly, the inter-trial interval was variable. Each participant completed three blocks of 90 trials each, with a 3 min rest break after each block of trials. Each block consisted of three conditions in a randomly intermingled order: (i) 54 valid conditions, where the target appeared in the square box indicated by the cue; (ii) 27 invalid conditions, where the target appeared in the contralateral square box indicated by the cue; and (iii) nine neutral conditions, where the target appeared without any cue. The probability of the targets being presented in the left and right square boxes was equal, and the arrow pointing to the right or left was random and equally probable. The procedure is summarized graphically in Fig. 1 .
Weight status and assessment of body composition
Standing height and weight measurements were performed using a Tanita WB-300 Plus digital scale (Tanita Corp., Tokyo, Japan), with participants wearing lightweight clothing and in bare feet. The BMI is defined as weight in kilograms divided by the square of height in metres. Although BMI is associated with body fat, the value does not provide direct information regarding body composition. Therefore, DXA (GE Lunar Prodigy, Madison, WI, USA) and enCore software (version 6.10.029; GE Lunar Corp, Madison, WI, USA) were applied to assess whole-body composition. In order to measure lean and fat masses as well as total body fat percentages, the subjects were requested to lie on the scanner table, and total body scans were then processed according to the manufacturer's standard instructions.
Cardiorespiratory fitness assessment
As aerobic capacity is considered to be the most accurate parameter of cardiorespiratory fitness, maximal oxygen uptake (V O 2 max ) using the Queen's College step test (QCST) was used to measure the maximal aerobic power of the obese and control groups in the present study (Joshi & Dhorepatil, 2014) . The QCST has shown that highly significant correlation (r = 0.96, P = 0.001) exists between the recovery heart rate in QCST andV O 2 max (Chatterjee, 2004) . The step test consisted of stepping up and down for a total duration of 3 min on a bench with a height of 41.275 centimeters at a rate of 24 steps min C.-L. Tsai and others and 22 steps min −1 for females. The desired rate of step cycles was guided using a metronome. After completion of the test, heart rates during the recovery were counted for 15 s, beginning 5 s after stepping ended, to calculate heart rate (in beats per minute). TheV O 2 max (in millilitres per kilogram per minute) for each participant was predicted based on the following expressions (McArdle et al. 1972; Joshi & Dhorepatil, 2014) : male, 111.33 − [0.42 × heart rate (in beats per minute)]; and female, 65.81 − [0.1847 × heart rate (in beats per minute)].
Electrophysiological recording and analysis
The EEG signals were collected from 18 electrode sites arranged in an electrocap (Quik-Cap; Compumedics Neuroscan, Inc., El Paso, TX, USA) based on the international 10-20 system, referenced to linked mastoid electrodes, with AFz placed on the mid-forehead serving as the earth electrode. Impedances were kept <5 k . To monitor possible artifacts attributable to eye movements, horizontal and vertical electrooculographic (HEOG and VEOG) activity was obtained using the adhesive ocular electrodes placed on the superolateral right canthus and inferolateral to the left eye, connected to the system reference. Continuous raw EEG signals were acquired with an A/D rate of 500 Hz per channel, a bandpass filter of 0.1-50 Hz, and a 60-Hz notch filter. These data were amplified by a SynAmps amplifier (Compumedics Neuroscan, Inc.) and written to hard disk for offline analysis using Neuroscan Scan 4.3 software (Neuro Inc., El Paso, TX, USA).
Before averaging the ERP P3 components, offline electrooculographic correction was applied to the individual trials using a spatial filter. All trials with a response error and artifacts (i.e. VEOG, HEOG and EMG exceeding ±100 μV) were discarded. The remaining effective ERP data were separately averaged offline across epochs constructed from two different conditions (e.g. invalid and valid, excluding the neutral condition, because the number of neutral trials was too few to perform the ERPs analysis). Relative to a 200 ms pre-cue baseline, the epoch for averaging was 1250 ms, including 550 ms before target stimulus onset. As the visuospatial attention protocol is more dependent on the activation of the parietal cortex and frontal lobes (Posner et al. 2007) , the target-elicited P3 components were thus calculated over the Fz, Cz and Pz electrodes in the present study. Two types of variables (i.e. P3 latency and P3 amplitude) were measured. The time window for peak detection of the P3 component was 280-700 ms for every participant (Gajewski et al. 2011; Tsai et al. 2014) . These windows were determined from inspection of the group grand average waveforms, and were equivalent for the ERP elicited by the two conditions and all the participants.
Blood sampling and analysis
Serum samples were collected in the morning (approximately 09.00-09.30 h) via venous blood withdrawal after a standard 12 h fast. Blood samples were allowed to clot (BD Vacutainer Plus) at room temperature (25°C) and then centrifuged at 1000g for 15 min at 4°C (Hettich Mikro 22R, C1110). The supernatant was aliquoted and stored at −80°C for future serum marker assays. The serum concentration of glucose was measured using an enzymatic kit (GLUCOSE liquicolor; HUMAN Gesellschaft für Ciochemica und Diagnostica; coefficient of variation <2%). Serum CRP was measured using a commercial enzyme-linked immunosorbent assay (ELISA) kit (CYT298, Human C-reactive protein ELISA kit; Merck Millipore, USA). Finally, multiplex analyses for various serum energy metabolic indices (e.g. insulin and leptin) and inflammatory indices (e.g. IL-6, IL-1β and TNFα) were conducted using a Milliplex Map kit (HBNMAG-51K; Merck Millipore, USA) and a Luminex R multiplexing instrument (Luminex 200; Merck Millipore, USA).
Data processing and statistical analysis
The neuropsychological performance was assessed with reaction times (RTs) to each target presentation automatically calculated by E-prime software, as well as the accuracy rate. The timing accuracy of the system was measured in milliseconds for the RT. An error was recorded according to three types: (i) orientation error (i.e. button-pressing error), the side of response inconsistent with the target side; (ii) anticipatory error, the response sooner than 150 ms; and (iii) delay error, response later than 2000 ms after target onset. The RTs were discarded if an error was recorded. To examine the inhibitory control of attention (i.e. interference control at the level of perception; Diamond, 2013), the attentional inhibition, as measured by the strength of inhibitory response effect, was calculated by subtracting the mean RT between valid and invalid trials (Theeuwes, 2010; Tsai et al. 2016a) .
The demographic characteristics and the differences in biochemical markers between the obese and healthyweight groups were compared by Student's unpaired t test. All neuropsychological and neurophysiological variables were analyzed with a repeated-measures analysis of variance (RM-ANOVA). For the neuropsychological performance of the visuospatial attention task, group (obesity versus healthy weight) was the between-subjects factor, and condition (valid versus invalid) was the within-subject factor, with the mean RTs and accuracy rates serving as the dependent variables. For the neurophysiological measures, group (obesity versus healthy weight) was the between-subjects factor, and condition (valid versus invalid) and electrode (Fz versus Cz versus Pz) were the within-subjects variables, with P3 latencies and amplitudes serving as the dependent variables. In addition, given that cardiorespiratory fitness is known to be associated with neurocognitive function (Tsai et al. 2014 (Tsai et al. , 2016b Wang et al. 2016) , if the main effects were obtained, the neuropsychological (e.g. RTs and accurate rate) and neurophysiological (e.g. P3 latencies and amplitudes) performances were separately analysed again using a repeated-measures analysis of covariance (RM-ANCOVA) to examine the effects on the neurocognitive deficits in relationship to obesity, with the averagedV O 2 max factor as a covariate. The homogeneity and normality of the variance assumptions were confirmed by the Levene and Lilliefors tests of the Kolmogorov-Smirnov test, respectively. Where a significant difference occurred, Bonferroni post hoc analyses were performed. Given that the correction factor reduces the degrees of freedom of the usual F-test and often results in non-integer values, only the corrected probability values and degrees of freedom are reported. The significance levels of the F ratios were adjusted with the Greenhouse-Geisser correction if the assumption of sphericity was violated. Partial η 2 (η p 2 ), a measure of effect size, was used for the group comparison to complement the significance testing, with the following standards used to determine the magnitude of the mean effect size: 0.01-0.059 representing a small effect, 0.06-0.139 a medium effect, and >0.14 a large effect (Cohen, 1973) .
Partial correlation coefficients, which controlled for the important potential confounding factor (i.e. cardiorespiratory fitness), were estimated to determine the strength of the associations between the biochemical markers (i.e. leptin, insulin, glucose, IL-6, IL-1β, TNFα and CRP) and neurocognitive performances (e.g. RTs in and across two conditions, the strength of inhibitory response effect, and P3 amplitudes collapsed across all electrode sites in and across two conditions). Stepwise, multiple linear regression analysis was also completed to determine the extent to which the biochemical markers were predictors of neurocognitive performances for the obese group and the control group, with the dependent variables being the neurocognitive performances that showed significant differences between obese and control groups, and the independent variables being the seven energy metabolic and inflammatory biomarkers. The analysis includedV O 2 max as a covariate in the models because it has been shown to be an important factor affecting cognition. Two-sided tests and a criterion α of 0.05 were adopted for all analyses. All statistical analyses were performed with the IBM SPSS Statistics package v.19 for Windows and with JMP version 4.0.4 (Academic).
Results
Demographic data
As shown in Table 1 , the weight and body composition status measures (e.g. BMI and percentage fat) differed significantly between the obese and healthy-weight (control) groups. In addition, the cardiorespiratory fitness levels also showed significant differences between the two groups, whereas the values of the other demographic measures revealed non-significant differences.
Neuropsychological indices
Accuracy rate (AR). The RM-ANOVA for the mean ARs showed that neither significant main effects of group [F(1,58) = 0.61, P = 0.438, η p 2 = 0.01] and condition [F(1,58) = 1.81, P = 0.183, η p 2 = 0.03] nor significant interactions between group and condition [F(1,58) = 0.02, P = 0.878, η p 2 < 0.01] were obtained.
Reaction time (RT).
As illustrated in Fig. 2 , the RM-ANOVA for the RT data revealed significant main effects of group [F(1,58) = 9.41, P = 0.003, η p 2 = 0.14] and condition [F(1,58) = 162.81, P < 0.001, η p 2 = 0.74], with the obese group (330.7 ± 25.3 ms) responding more slowly than the control group (310.6 ± 25.4 ms) in both conditions, and the valid condition (308.7 ± 25.4 ms) showing a significant difference with regard to the invalid condition (332.6 ± 30.6 ms) in both groups. These main effects were superseded by the group × condition interactions [F(1,58) = 6.11, P = 0.016, η p 2 = 0.10]. Post hoc analysis showed that the average value of the attentional inhibition, as measured by the strength of the inhibitory response effect (invalid RT-valid RT), was significantly larger in the obese group compared with the control group [control versus obese: 19.3 ± 12.0 versus 28.5 ± 16.7 ms; t(58) = −2.47, P = 0.017, Cohen' 
Given that cardiorespiratory fitness is a confounding factor with regard to RT performance of visuospatial attention in young adults (Wang et al. 2016) , and the obese group has significantly lowerV O 2 max values compared with the control group, the cognitive neuropsychological index, RT, accounted for cardiorespiratory fitness using an ANCOVA procedure. The results of RM-ANCOVA on the averaged RTs in both conditions still indicated significant main effects of group [F(1,57) = 7.88, P = 0.007, η p 2 = 0.12], as well as the group × condition interaction [F(1,57) = 9.20, P = 0.004, η p 2 = 0.14].
Neurophysiological indices P3 latency. As shown in Fig. 3 , the RM-ANOVA for the P3 latency data showed that there was a significant effect of electrode [F(2,116) = 12.40, P < 0.001, Grand averaged event-related potential waveforms in the valid and invalid conditions in three electrodes (Fz, Cz and Pz) for the healthy-weight (control) and obese groups Endocrine and neurocognitive performance in obesity 35 μV) , the valid condition (3.12 ± 3.25 μV) showing a significant difference with regard to the invalid condition (3.85 ± 3.61 μV) in both groups, and the P3 amplitude at the Fz site (2.37 ± 3.39 μV) being significantly smaller than that those at the Pz (4.11 ± 3.07 μV) and Cz sites (3.98 ± 3.58 μV). No significant interactions among group, condition and electrode were exhibited [group × condition: F(1,58) = 0.73, P = 0.397, η p 2 = 0.01; group × electrode: F(2,116) = 0.25, P = 0.778, η p 2 < 0.01; group × condition × electrode: F(2,116) = 0.17, P = 0.856, η p 2 < 0.01]. Given that cardiorespiratory fitness is a confounding factor on the P3 amplitude performance of visuospatial attention in young adults (Wang et al. 2016) , and the obese group has significantly lowerV O 2 max values than the control group, the neurophysiological index, P3 amplitude, accounted for cardiorespiratory fitness using an ANCOVA procedure. The results of RM-ANCOVA on the averaged P3 amplitude in both conditions and three electrodes still indicated a significant group difference [F(1,57) = 6.27, P = 0.015, η p 2 = 0.10], as noted above.
Biochemical indices
As seen in Table 2 , the serum concentrations of the energy metabolic indices (e.g. leptin, insulin and glucose) showed substantial group differences (all P < 0.05). In terms of inflammatory biomarkers, the control and obese groups had comparable TNFα, IL-6 and IL-1β concentrations, but the serum concentrations of CRP showed a significant group difference. There were no significant differences between the correlations estimated separately for the neurocognitive performances and five biomarkers (i.e. glucose, insulin, TNFα, IL-6 and IL-1β) for the control and obese groups.
Partial correlations, controlled for cardiorespiratory fitness, between biochemical markers and neurocognitive performances showed that the serum concentrations of leptin were negatively correlated with P3 amplitude across electrodes in the control group (r = −0.52, P = 0.004 in valid condition; r = −0.53, P = 0.003 in invalid condition; r = −0.54, P = 0.002 across both conditions). The stepwise regression analysis, independent of the cardiorespiratory fitness factor, revealed that leptin was a significant independent determinant of P3 amplitude in the model in the control group, explaining 25.7% of the variability (adjusted R 2 ) [ F(1,27) = 11.01, β = 0.001, t(29) = 3.32, P = 0.003]. In terms of the obese group, P3 amplitude across electrodes was negatively correlated with both the serum concentrations of leptin (r = −0.39, P = 0.035 in valid condition; r = −0.47, P = 0.010 in invalid condition; r = −0.52, P = 0.004 across two conditions) and CRP (r = −0.38, P = 0.040 across both conditions; see Fig. 4 ). However, the stepwise regression analysis, independent of the cardiorespiratory fitness factor, revealed that only leptin was a significant independent determinant of P3 amplitude in the model in the obese group, explaining 26.4% of the variability (adjusted R 2 ) [ F(1,27) = 9.89, β = −6.79 × 10 −5 , t(29) = −3.14, P = 0.004]. In addition, the P3 amplitude across electrodes and conditions was negatively related to the body fat percentage, as measured by DXA, in the all participants (r = −0.42, P = 0.001) and in the obese group (r = −0.46, P = 0.011).
Discussion
Main findings
The present study was designed to explore the neurophysiological mechanism of the deficit of visuospatial attention in adults with obesity and to investigate the relationship between neurocognitive performances and the biochemical markers known to be associated with both obesity and cognitive dysfunction. The main finding was that although the obese and control groups showed comparable accuracy rates and P3
C.-L. Tsai and others latencies, the obese group exhibited slower RTs and smaller P3 amplitudes, even after adjusting for the cardiorespiratory fitness factor, suggesting that, to some extent, adults with obesity showed deviant problems in neuropsychological and neurophysiological performances compared with healthy-weight counterparts in the present study. Moreover, serum concentrations of leptin, insulin, glucose and CRP were significantly higher in the obese group compared with the control group, except those for IL-6, IL-1β and TNFα. Only leptin and CRP were significantly correlated with the P3 amplitude in the adults with obesity, even when controlling for cardiorespiratory fitness. None of the associations between the other hormones that were examined and neurocognitive performances was significant. Leptin was the sole predictor of P3 amplitude in the regression analysis model in the obese group.
Neuropsychological indices
In the present study, adults with obesity showed comparable ARs to those of the healthy-weight controls. Hence, the differences of RTs between the two groups could be attributed to the differences in the time efficiency of the central processing of cognitive functions, and not to any speed-accuracy trade-off. Although consistent with many earlier studies examining the relationship between obesity and cognitive neuropsychological performance, and showing a negative association between cognition (especially in the attention aspects) and obesity in adults (Cournot et al. 2006; Cserjési et al. 2009; Fergenbaum et al. 2009 ), the present study extended previous knowledge and found that adults with obesity showed significantly prolonged RTs across all conditions, and poorer attentional inhibition when performing the visuospatial attention task. These findings suggest that adults with obesity could be less efficient in dealing with the cue-target sequence and have worse inhibitory control of attention with regard to orienting it towards the falsely indicated location when compared with the healthy-weight adults. Previous studies found that individuals with obesity have significantly less grey matter volume in the brain areas (e.g. orbitofrontal cortex) involving response inhibition (Raji et al. 2010; Horstmann et al. 2011; Maayan et al. 2011) , which could, in part, explain the neuropsychological problems of attention. It is worth noting that the association between obesity and poorer visuospatial attention information processing (e.g. slower RTs and lower attentional inhibition) was also recently found in children (Tsai et al. 2016a) . Previous studies reported that children with obesity show reduced attention and cognitive flexibility and that such problems can still be exhibited during adulthood (Cserjési et al. 2007 (Cserjési et al. , 2009 . Therefore, weight status could be related to the visuospatial attention networks that have been implicated in executive functions across lifespan (Carnell et al. 2012) .
Neurophysiological index
P3 activity may help to determine early abnormalities in neurophysiological performances, because such an ERP component could be a sensitive clinical indicator to identify neurological deficits, neurotransmitter deficiencies and cognitive declines, especially in individuals who are already suffering from progressive cognitive impairments. In the present study, adults with obesity showed comparable P3 latencies to the healthyweight control subjects, suggesting that obesity does not compromise the speed of cognitive stimulus proceing and response selection in the adults when performing the visuospatial attention task (Polich, 2007) , which was also found in children with obesity (Tsai et al. 2016a ). However, the obese relative to the control group exhibited significantly smaller P3 amplitudes in the present study, which is in accordance with an earlier study that also investigated the ERPs to targets preceded by valid and invalid cues in children with obesity (Tsai et al. 2016a) and supports the view that individuals with obesity exhibit reduced attentional focus or less efficient allocation of attentional resources when performing the visuospatial attention task (Polich, 2007) . Likewise, previous studies reported that individuals with obesity showed less activation in areas involving object processing and attention than normal-weight individuals (Carnell et al. 2012) , and there was a negative correlation between the body fat percentage and P3 amplitude across conditions when obese subjects performed an oddball protocol to assess the attentional cortical response (Babiloni et al. 2009 ). In the present study, the P3 amplitude across electrodes and conditions was also negatively related to the body fat percentage, as measured by DXA. The present and previous findings may reflect that individuals with obesity/higher body fat have impairments in the neural activity in the brain areas involved in several brain circuits (e.g. the frontoparietal cortices) signalling perceptual processes, attention, executive and motor functions (Stice et al. 2008; Carnell et al. 2012; García-García et al. 2015) . In addition, as dopaminergic transmission is strongly associated with attentive neural processing (e.g. the strength of the P3 signals; Neuhaus et al. 2009) , and having fewer striatal dopaminergic receptors is related to obesity (Wang et al. 2001) , the finding that the obese group in the present study showed weaker attentive neural processing (i.e. attenuated P3 amplitudes) seems to support that fewer striatal dopaminergic receptors could be the potential mechanism of the deficit of visuospatial attention in individuals with obesity. Considered jointly with the neuropsychological performances in the present study, the smaller P3 amplitudes in the obese group could also partly explain the longer RTs because of poorer cognitive resource allocation (Muller & Knight, 2002) .
Biochemical indices
Obesity is considered to be a low-grade pro-inflammatory state, which can elevate the blood concentrations of inflammatory cytokines and chemokines (e.g. TNFα, IL-6 and IL-1β; Reinehr et al. 2005; Park et al. 2010; Toffanin et al. 2010) and acute reactive proteins (e.g. CRP; Quasim et al. 2004) . Given that these inflammatory proteins have been shown to be associated with cerebral atrophy (Whitmer, 2007) , neuronal degradation and reduced total brain volume (Jefferson et al. 2007) , inflammatory processes are known to have adverse impacts on cognitive function (Peila & Launer, 2006) . Unexpectedly, the young adults with obesity in the present study did not show significant differences in these biomarker concentrations when compared with their age-matched normal-weight peers. The findings ight indicate that there are no significant relationships between these inflammatory cytokines and neurocognitive performance, which is somewhat inconsistent with previous animal studies suggesting that obesity-induced chronic low-grade inflammation constitutes a pathway causing impaired cognition much earlier, independently of the obesity-induced comorbidities (Bilbo & Tsang, 2010; Pistell et al. 2010) . However, with the exception of the above-mentioned pro-inflammatory cytokines, and in line with previous studies (Quasim et al. 2004; Spyridaki et al. 2014) , the concentrations of CRP, the most conventional and robust marker of chronic low-grade inflammation in obesity (Aronso et al. 2004; Ishii et al. 2012) , were significantly higher in the obese adults relative to the control subjects in the present work. Additionally, such an acute reactive protein in the adults with obesity was significantly related to poorer neurophysiological (i.e. P3 amplitude) performance. To date, no previous studies have explored the relationship between CRP and neurocognitive performances in individuals with obesity. However, the finding of the present work could, at least in part, receive support from a previous study, which investigated the correlation of increased CRP concentrations with cognitive decline owing to high-altitude exposure and found that poorer P3 performance (i.e. P3 latency) showed a significant association with CRP (Hu et al. 2016) . Likewise, a number of studies have clearly indicated a positive relationship between peripheral blood concentrations of CRP and neurocognitive decline (Noble et al. 2010; Bettcher et al. 2012) and, additionally, increasing concentrations of CRP have been associated with loss of brain white matter integrity in the corticosubcortical pathways and association fibres of the frontal and temporal lobes, independent of age and sex (Miralbell et al. 2012) . However, in the present study the CRP was not a significant independent determinant of P3 amplitude in the obese group when analysed further using regression analysis. This finding suggests that, although CRP is inversely correlated with ERP P3 amplitudes, it may not be a potential biomarker for the prediction of obesity-induced neurocognitive dysfunction in adults. Nevertheless, it is still worth noting that previous studies reported that chronically increased concentrations of circulating CRP in young adults with obesity may lower late-life cognitive ability and increase the risk of developing dementia (Schmidt et al. 2002; Marioni et al. 2009) , although further studies are necessary to strengthen the present findings and to determine the exact mechanism of neurocognitive impairment in individuals with obesity.
The values for fasting glucose in the present study implied that none of the obese participants met the criteria for diabetes mellitus. However, significantly higher fasting serum insulin and glucose concentrations were observed in the obese adults compared with the control subjects. These findings are compatible with Messier et al.'s (2011) finding of significantly positive associations between BMI and insulin and glucose concentrations (i.e. glucoregulation) in young non-diabetic adults. Although chronic peripheral hyperinsulinaemia can reduce insulin transport into the brain (Craft, 2005) , and brain insulin receptors have been shown to have reduced sensitivity to insulin in obese individuals (Kaiyala et al. 2000) , which could result in poor glucoregulation and further cognitive declines, the higher fasting insulin and glucose concentrations were not significantly correlated with poorer neurocognitive performance in the present study. However, the potential problems that insulin resistance contributes to cerebral atrophy and neurodegeneration (Cholerton et al. 2011) should be noted in obese adults. In addition, the obese adults in the present study showed significantly higher concentrations of fasting blood glucose compared with the healthy-weight cohort, which could increase the chances of white matter hyperintensity and ischaemic cerebrovascular disease. This may in turn cause cerebral atrophy and neuronal apoptosis through impaired blood flow to the neurovascular unit (Weinstein et al. 2015) . Therefore, the finding of chronic peripheral hyperinsulinaemia and poor glucoregulation in the adults with obesity in the present study still needs to be considered with caution.
The obese adults showed significantly higher concentrations of leptin relative to the control group in the present study. In addition, we also found that obesity had a significant relationship with higher serum leptin concentrations and smaller P3 amplitudes, not only in either the valid or invalid conditions, but also across the two conditions, suggesting that leptin resistance may reduce electrophysiological activity during the cognitive processing involving visuospatial attention (e.g. the disengaging, moving and engaging procedure of attention). Most importantly, even when the CRP was also correlated with the neurophysiological performance in the present study, the leptin concentration was the sole predictor in the obese group, further implicating leptin as a likely mechanism of the cognitive deficits seen with obesity. Indeed, a previous study showed that higher leptin concentrations were associated with a smaller right putamen, left postcentral gyrus and grey matter volume in the left inferior frontal operculum in young adults (Pannacciulli et al. 2007) . Obese animals are unable to respond to leptin because dysfunctional leptin receptors have impairments in long-term potentiation and synaptic plasticity, and this leads to deficiencies in spatial learning (Li et al. 2002; Gerges et al. 2003) . Moreover, elevated blood leptin concentrations may decrease neuronal excitability (Erbayat-Altay et al. 2008) . Although leptin could facilitate neuronal excitability and improve cognitive functions for some neuropathological conditions (e.g. Alzheimer's disease, Parkinson's disease and epilepsy; Folch et al. 2012) , CNS insensitivity to leptin could play a role in the cognitive impairments seen in individuals with obesity because of leptin resistance at the level of the blood-brain barrier (Banks, 2004) . Therefore, leptin resistance and the subsequent higher concentrations of leptin in the adults with obesity found in the present study could be the most important factor associated with neurocognitive declines.
Strengths and limitations
Although the DXA was used to reflect the participants' body fat contents exactly, and the confounding factors (e.g. cardiorespiratory fitness) with regard to the neurocognitive performance of visuospatial attention in young adults (Wang et al. 2016) were rigorously controlled in the present work, there are still some potential limitations to the cross-sectional study design. Previous research demonstrated that poor performance in executive functioning is a risk factor for increased BMI (Guxens et al. 2009) , suggesting the bidirectional relationship between cognition and obesity. In addition, low vegetable and fruit intake and less physical activity can be predicted by low levels of executive functioning (Riggs et al. 2010) , and diet contents are associated with some obesity-related biomarkers, such as inflammatory factors and leptin (de Koning et al. 2012) , which have also been implicated in the regulation of food intake because of alterations in neuronal excitability (Harvey, 2007) . Further work is thus needed to clarify the possible relationships between executive functioning, biomarkers and BMI/fat contents via long-term diet or physical activity intervention. In addition, the young obese adults without obvious obesity-related comorbidities (e.g. cardiovascular disease or diabetes) in the present study could be more resistant to cognitive declines and be healthier than middle-aged and elderly adults, which would be likely to cause this study to underestimate the effects of obesity-related biochemical markers on neurocognitive performance within the general population. However, conversely, this could also be one of the strengths of the present work. As obesity often coexists with other medical conditions (e.g. hypertension and diabetes) known to be independently associated with cognitive deficits, the relationships between poorer neurocognitive performances and obesity-induced metabolic and inflammatory biomarkers seem to be reflected clearly in the young adults with obesity free of other serious medical conditions or mental disorders in the present study.
Conclusions
In sum, adults with obesity or higher fat contents showed poorer neuropsychological performances (e.g. slower RTs and worse inhibitory control of attention) and aberrant neural activity (e.g. smaller P3 amplitudes) associated with cognitive information processing when performing the visuospatial attention task, and higher serum concentrations of CRP and energy metabolic indices (e.g. leptin, insulin and glucose) in the present study. The higher leptin and CRP concentrations found in the adults with obesity were significantly and negatively associated with lower P3 amplitudes. However, leptin was the sole predictive factor in the obese group, further implicating that, in conjunction with the known effects of leptin as a neuromodulator and the desensitizing effects on central leptin receptors, hyperleptinaemia is a determinant for the altered neurocognitive function observed in obesity.
Obesity in young adulthood has been associated with adverse neurocognitive effects and early onset of type 2 diabetes (D'Adamo & Caprio, 2011) , and alterations in the lipid metabolism and chronic low-grade inflammation have been associated with neurodegenerative disorders, in particular with Alzheimer's disease (Schmidt et al. 2002; Lieb et al. 2009; Marioni et al. 2009 ). Therefore, both conditions (i.e. deviant neurocognitive performances and biochemical makers) should be taken into account as obesity-related health issues in young adults in clinical practice. It is worth noting that long-term exercise seems to be an effective way to decrease CRP and leptin concentrations independently of changes of body fat percentage and insulin concentrations in males with obesity (Pasman et al. 1998; Shih et al. 2010) . Further studies could focus on examining the relationship between exercise, biomarkers and obesity-related cognitive deficits, because these might provide better understanding of the potential mechanisms of the neurocognitive deficits of visuospatial attention seen in relationship to obesity.
